This list is an analysis based on recent market events. It's not an investment recommendation.
About
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. The company was incorporated in 1990 and is based in Bengaluru, India.
What is Strides Pharma Science stock price today?▼
The current price of STAR.NSE is ₹1,053.8 INR — it has increased by +0.18% in the past 24 hours. Watch Strides Pharma Science stock price performance more closely on the chart.
What is Strides Pharma Science stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Strides Pharma Science stocks are traded under the ticker STAR.NSE.
Is Strides Pharma Science stock price growing?▼
STAR.NSE stock has risen by +5.59% compared to the previous week, the month change is a +12.07% rise, over the last year Strides Pharma Science has showed a +61.65% increase.
What is Strides Pharma Science market cap?▼
Today Strides Pharma Science has the market capitalization of 97.13B
When is the next Strides Pharma Science earnings date?▼
Strides Pharma Science is going to release the next earnings report on May 21, 2026.
What were Strides Pharma Science earnings last quarter?▼
STAR.NSE earnings for the last quarter are 22.34 INR per share, whereas the estimation was N/A INR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A INR per share.
What is Strides Pharma Science revenue for the last year?▼
Strides Pharma Science revenue for the last year amounts to 87.83B INR.
What is Strides Pharma Science net income for the last year?▼
STAR.NSE net income for the last year is 71.87B INR.
Does Strides Pharma Science pay dividends?▼
Yes, STAR.NSE dividends are paid annual. The last dividend per share was 4 INR. As of today, Dividend Yield (FWD)% is 0.38%.
How many employees does Strides Pharma Science have?▼
As of April 29, 2026, the company has 3,301 employees.
In which sector is Strides Pharma Science located?▼
Strides Pharma Science operates in the Health & Wellness sector.
When did Strides Pharma Science complete a stock split?▼
Strides Pharma Science has not had any recent stock splits.
Where is Strides Pharma Science headquartered?▼
Strides Pharma Science is headquartered in Bengaluru, India.